Skip to main content

MINI REVIEW article

Front. Oncol.
Sec. Gynecological Oncology
Volume 14 - 2024 | doi: 10.3389/fonc.2024.1487008

Progestin-based pharmacotherapy in fertility preservation in early endometrial cancer：A Minireview

Provisionally accepted
ZhenDong Qin ZhenDong Qin Hua Li Hua Li *
  • Beijing Chaoyang Hospital, Capital Medical University, Beijing, China

The final, formatted version of the article will be published soon.

    In recent years, as the age of onset of the disease has gradually become younger, this has caused distress to some young patients with reproductive needs, and the active search for methods of preserving reproductive function has gradually attracted attention.In this paper, we will systematize the current status of progestin-based pharmacotherapy in combination with other drug therapies in the conservative management of early-stage endometrial cancer. With the expectation of providing a reference for the treatment of early stage endometrial cancer patients in China and for the in-depth development of related research in this field.

    Keywords: progestin, endometrial cancer, conservative treatment, retention of fertility, Drug Therapy

    Received: 28 Aug 2024; Accepted: 14 Oct 2024.

    Copyright: © 2024 Qin and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Hua Li, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.